Canada markets closed

China Shineway Pharmaceutical Group Limited (C1S.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.0800-0.0100 (-0.92%)
At close: 03:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 922.33M
Enterprise Value 199.86M
Trailing P/E 6.61
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.41
Price/Book (mrq)0.99
Enterprise Value/Revenue 0.04
Enterprise Value/EBITDA 0.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 30.93%
S&P500 52-Week Change 322.38%
52 Week High 31.2300
52 Week Low 30.7700
50-Day Moving Average 31.1047
200-Day Moving Average 30.9297

Share Statistics

Avg Vol (3 month) 3106
Avg Vol (10 day) 3N/A
Shares Outstanding 5827M
Implied Shares Outstanding 6846.17M
Float 8207.04M
% Held by Insiders 166.31%
% Held by Institutions 14.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.07
Forward Annual Dividend Yield 46.38%
Trailing Annual Dividend Rate 30.42
Trailing Annual Dividend Yield 338.53%
5 Year Average Dividend Yield 46.28
Payout Ratio 432.88%
Dividend Date 3N/A
Ex-Dividend Date 4Apr 29, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 21.47%
Operating Margin (ttm)18.14%

Management Effectiveness

Return on Assets (ttm)6.81%
Return on Equity (ttm)14.45%

Income Statement

Revenue (ttm)4.52B
Revenue Per Share (ttm)5.98
Quarterly Revenue Growth (yoy)-0.80%
Gross Profit (ttm)N/A
EBITDA 1.14B
Net Income Avi to Common (ttm)969.51M
Diluted EPS (ttm)0.1600
Quarterly Earnings Growth (yoy)22.10%

Balance Sheet

Total Cash (mrq)5.91B
Total Cash Per Share (mrq)7.83
Total Debt (mrq)301.33M
Total Debt/Equity (mrq)4.28%
Current Ratio (mrq)3.35
Book Value Per Share (mrq)9.31

Cash Flow Statement

Operating Cash Flow (ttm)932.64M
Levered Free Cash Flow (ttm)601.34M